Levodopa/Carbidopa
- Generic Name
- Levodopa/Carbidopa
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Impax Laboratories, LLC
- Target Recruit Count
- 27
- Registration Number
- NCT00869791
- Locations
- 🇺🇸
IMPAX Laboratories, Hayward, California, United States
Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Jaeb Center for Health Research
- Target Recruit Count
- 33
- Registration Number
- NCT00789672
- Locations
- 🇺🇸
Wilmer Eye Institute, Baltimore, Maryland, United States
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
Phase 4
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2006-10-25
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Novartis
- Target Recruit Count
- 95
- Registration Number
- NCT00391898
- Locations
- 🇪🇸
Fundación Hospital de Alcorcón, Alcorcón (Madrid, Spain
🇪🇸Centro Médico Teknon, Barcelona, Spain
🇪🇸Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain
Medications for Stopping Cocaine Dependence and Preventing Relapse
Phase 2
Completed
- Conditions
- Cocaine AbuseCocaine-Related Disorders
- Interventions
- Drug: PlaceboBehavioral: Motivational Interviewing (MI)Behavioral: Contingency management (CM)Behavioral: Cognitive-Behavioral Therapy (CBT)
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-06-09
- Target Recruit Count
- 101
- Registration Number
- NCT00218023
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Stalevo in Early Wearing-Off Patients
Phase 4
Completed
- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2009-06-22
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 223
- Registration Number
- NCT00125567
- Locations
- 🇬🇧
Movement Disorder Services, Chertsey, Surrey, United Kingdom
🇬🇧University Hospital of Wales, Cardiff, Wales, United Kingdom
🇫🇮Tampere University Hospital, Tampere, Finland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath